BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer at BostonGene will deliver multiple presentations ...

Tumor metabolomics is an emerging field focused on understanding the metabolic alterations that occur in tumor cells and their surrounding microenvironment. These changes are essential to support the ...

Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...

A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Cancer cells continuously interact with their surrounding microenvironment, critically influencing tumor development, metastasis, immune evasion, and therapy resistance. Metabolic reprogramming in ...

Pancreatic cancer cells are known for being hard to treat, partly because they change the environment around them to block drugs and immune cells. Scientists discovered that these tumors use a ...